These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34285498)

  • 1. The Contrasting Perceptions and the Cause Regarding Patenting Technologies Between Academic Medical Researchers and Pharmaceutical Companies Based in Japan.
    Sugimitsu K; Manome Y
    J Multidiscip Healthc; 2021; 14():1795-1805. PubMed ID: 34285498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patenting trends by Mexican pharmaceutical companies.
    Villafaña-Diaz L; Perez-Garcia JC; Barron-Villaverde D; Perez-Santos M
    Pharm Pat Anal; 2023 Nov; 12(6):275-286. PubMed ID: 38197381
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of intellectual property generated by biomedical research at universities and academic hospitals.
    Heus JJ; de Pauw ES; Mirjam L; Margherita M; Michael R H; Michal H
    J Clin Transl Res; 2017 May; 3(2):250-259. PubMed ID: 30873476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conotoxin Patenting Trends in Academia and Industry.
    Sanchez-Campos N; Bernaldez-Sarabia J; Licea-Navarro AF
    Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents.
    Jiang Q; Luan C
    Global Health; 2018 Aug; 14(1):92. PubMed ID: 30165885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inventions and Patents: A Practical Tutorial.
    Mehta H; Tidwell L; Liotta LA
    Methods Mol Biol; 2017; 1606():379-397. PubMed ID: 28502014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system.
    Kesselheim AS
    AAPS J; 2007 Aug; 9(3):E306-11. PubMed ID: 17915832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expired patents: An opportunity for higher education institutions.
    Mafu M
    Front Res Metr Anal; 2023; 8():1115457. PubMed ID: 37008286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology Transfer: From the Research Bench to Commercialization: Part 1: Intellectual Property Rights-Basics of Patents and Copyrights.
    Van Norman GA; Eisenkot R
    JACC Basic Transl Sci; 2017 Feb; 2(1):85-97. PubMed ID: 30167556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Unitary Patent and UPC - Implications for the pharmaceutical sector.
    Mummery Z
    Drug Discov Today; 2022 Dec; 27(12):103388. PubMed ID: 36195203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intellectual property in entomology: Analysis and perspective on recent trends in global patent publications.
    Hamm RL; Gregg A; Sparks TC
    Pest Manag Sci; 2020 May; 76(5):1603-1611. PubMed ID: 32034856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry-university collaborations in Canada, Japan, the UK and USA--with emphasis on publication freedom and managing the intellectual property lock-up problem.
    Kneller R; Mongeon M; Cope J; Garner C; Ternouth P
    PLoS One; 2014; 9(3):e90302. PubMed ID: 24632805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.